News-Zhongshan Laibo Ruichen Biomedicine Co., Ltd.

16984638634831788

News

微信图片_20260326123456_1891_240(1)

Class 1 Innovative Drug for Knee Osteoarthritis Launches Phase 1b Clinical Trial in Peking Union Medical College Hospital

The 2nd Meeting of the 2nd Board of Directors & 2025 Annual Shareholders' Meeting of Rabpharma Successfully Concluded

v2-61f4602ae0e0db137524df3557bbfdfc_720w

Rabpharma Successfully Recognized as a National High-tech Enterprise

45b598335b66314cecbd3862d162dec9

Rabpharma's RAB001 Secures Additional IND Clearance, Expanding into Osteoarthritis

调亮了d6112(1)(1)(1)(1)

Patient enrollment has been completed for the RAB001 Phase II clinical trial!

1 2 3 4 5

info@rabpharma.com